Royalty Pharma plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Royalty Pharma plc has filed 592 SEC EDGAR filings since 13 Feb 2020

SEC filing history

Showing 26-50 of 592 matching filings.

Per page
25
Current page
2
13F-NT File 028-26788

13F-NT filing

Filing date
01 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Mar 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Mar 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
23 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
19 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
18 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
04 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Feb 2026
Reporting date
23 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
23 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91540

SCHEDULE 13D/A filing

Filing date
20 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91540

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2026
Reporting date
02 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
03 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39329

144 filing

Filing date
02 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Feb 2026
Reporting date
30 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jan 2026
Reporting date
23 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .